- Home
- KRSA vs CET Comparison
KRSA vs CET Comparison
Compare KRSA & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRSA | CET |
|---|---|---|
| Founded | 2024 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRSA | CET |
|---|---|---|
| Price | $30.08 | $55.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | ★ 144.5K | 25.4K |
| Earning Date | 11-16-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.76% |
| EPS Growth | ★ 8.26 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,074,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.93 |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $29.03 | $47.82 |
| 52 Week High | $37.27 | $57.39 |
Technical Indicators
Market Signals| Indicator | KRSA | CET |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 57.06 |
| Support Level | $29.67 | $54.66 |
| Resistance Level | $35.78 | $57.17 |
| Average True Range (ATR) | 2.32 | 0.87 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 23.33 | 75.00 |
Price Performance
Historical ComparisonAbout KRSA Korsana Biosciences Inc. Common Stock
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. The company's investment objective is long-term growth of capital. It invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.